Thursday, March 24, 2011

Research and Markets: Remifentanil - Key patent, SPC, and data exclusivity ... - Business Wire (press release)

http://sootheze.com/toasty-collar-collection.php


Research and Markets: Remifentanil - Key patent, SPC, and data exclusivity ...

Business Wire (press release)


The 'Key Patent Indicator' section is intended to provide an indication of the Key Patents pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive patent search can be found in the corresponding Pipeline ...



and more »

No comments:

Post a Comment